Penn Medicine Provider
Radiology
Anne Hae mee King, DO
she/her/hers
Accepting new patients
Sees patients age 18 and up

About me

Education and training

  • Medical School: University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine
  • Residency: Frankford Hospital
  • Residency: Temple University Hospital
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. King is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Clara Stoughton, MSIV and Anne King, DO AMSER Case of the Month February 2025- Male Breast Cancer , The Alliance of Medical Student Educators in Radiology : 2025


Kris Coppin, MSIV, Anne King, DO, Susan Summerton, MD AMSER Medical Student Case of the Month-Breast , The Alliance of Medical Student Educators in Radiology: 2022


KumarG, Kim AH, KrefetzD, Steer R. Screening for major depressive disorder in adolescent psychiatric inpatients with the mood modules from the primary care evaluation of mental disorders and the patient health questionnaire. , Psychological Reports, 89: 2001,274-278


Takanishi DM Jr, Kim SY, Kelemen PR, Yaremko ML, Kim AH, Ramesar JE, Horrigan SK, MontagAG, Michelassi F, Westbrook CA. Chromosome 8 losses in colorectal carcinoma: Localization andcorrelation with invasive disease. , Molecular Diagnosis, 2: 1997,3-10


Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson R. PCR-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. , Blood Vol, 88: 1996,2665-2670


Takanishi DM Jr, WestbrookCA, Kelemen PR, Yaremko ML, Kim AH, Ramesar JE, Horrigan SH, Montag AF, Michelassi F. Chromosome 8p loss in colorectal cancer correlates with tumorinvasiveness. , Proc. Amer. Soc. of Clinical Onc, 14: 1995,157


Horrigan SK, Ramesar RS, Kim AH, Yamaoka LH, Vance JM, Westbrook CA. Identification of aminimal deletion associated with del (5q) in acute myeloid leukemia and myelodysplasia. , Proc.Amer.Assoc. Cancer Res., 65(521): 1995


Kelemen PR, Yaremko ML, Kim AH, Westbrook, CA. Chromosome 8 tumor suppressor gene incolorectal cancer: mapping by PCR on paraffin-embedded clinical specimens. , 47th Meeting Society of Surgical Oncology: 1994


Kelemen PR, Yaremko ML, Kim AH, Montag AG, Michelassi F, Westbrook CA. Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma , Chromosomes and Cancer, 11: 1994,195-198


Takanishi DM Jr, Kelemen PR, Kim AH, Yaremko ML, Horrigan SK, Montag AG, Michelassi F, Westbrook CA. Chromosome 8 deletions in colorectal carcinoma (CRC): localization and clinical significance. , Am J Hum Genet, 55: 1994,A388